Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Paving the Way as Biosynthesis Promises to Revolutionize Drug Development

Forbes predicts medical marijuana sales to reach $13.3 billion by 2020 Biotech/pharma market could surpass $20 billion by 2020, per estimates from Viridian Capital Advisors InMed’s biosynthesis process uses DNA and E. coli to produce cannabinoids that are identical to the 90+ found in nature The company’s pipeline drugs, focusing on rare dermatological diseases, glaucoma […]

EVIO, Inc. (EVIO) is “One to Watch”

Rapidly expanding network of analytical cannabis testing laboratories now serving five states Accurate, reliable lab results based on scientific principles using state-of-the-art facilities Analytical services include testing cannabis flowers, extracts and infused products EVIO, Inc. (OTCQB: EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory […]

Skinvisible, Inc. (SKVI) is “One to Watch”

Patented technology enhances how topical and transdermal drugs and skin care products are delivered Polymer delivery vehicle can be tailored to almost any type of molecule including the medicinal components of hemp and marijuana 14 patents granted in the U.S. and internationally $65 billion market in dermatology, pharmaceutical and other healthcare industries offers strong growth […]

Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) Enters Agreement for Sustained Release Cannabinoid Formulation

Companies collaborating on development of patent-pending sustained release oral cannabinoid formulation Formulation doubles or triples time period in which cannabinoid doses maintain their therapeutic effects Formulation enables better regulation of dosing schedules and improvement of patient compliance Emblem Corp. (TSX.V: EMC) (OTC: EMMBF), a company licensed to cultivate and sell medical marijuana in Canada under […]

Marijuana Company of America, Inc. (MCOA) is “One to Watch”

Strategic approach to cannabis and hemp industry through networking architecture Legal marijuana markets estimated to reach $22.6 billion by 2021 Branded “hempSMART Brain™” CBD product is first to be offered by direct market Wellness industry is now $1.9 trillion per year with huge growth potential The founders of Marijuana Company of America, Inc. (OTC: MCOA) […]

SinglePoint, Inc. (SING) – An Evolutionary Success Tale

Diversified portfolio for sustainable growth offers multiple revenue options Entry into legalized cannabis market continues with acquisition of multiple cannabis companies Ancillary cannabis-related businesses poised to reap healthy portion of multi-billion-dollar industry SinglePoint, Inc. (OTC: SING) has evolved from a full-service provider of mobile technology to a publicly traded holding company focused on diversifying into […]

 

From Our Blog

Improving the Odds: How LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is Working to Make Cancer Therapies More Effective

February 4, 2026

Despite decades of progress in oncology, many cancers remain resistant to treatment, not because therapies are unavailable, but because tumor cells adapt. Immunotherapies and chemotherapies can produce meaningful responses, yet durability and consistency remain challenges, particularly in aggressive or rare cancer subtypes. Increasingly, research is shifting toward approaches that improve how well existing treatments work, […]

Rotate your device 90° to view site.